Status:
COMPLETED
Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
EMD Serono
Conditions:
Infertility
Eligibility:
FEMALE
21-39 years
Phase:
PHASE4
Brief Summary
The goal of this research study is to compare the pregnancy rates for two different types of progesterone supplementation after in-vitro fertilization (IVF).
Detailed Description
The aim is to test the hypothesis that the pregnancy rates of women under age 40 undergoing an in vitro fertilization and embryo transfer (IVF-ET) cycle are not different with respect to the administr...
Eligibility Criteria
Inclusion
- Women of reproductive age (21-39) with infertility who are appropriate candidates for IVF/ET and have an FSH \< 15 mIU/ml
- Women 21 to 39 years of age who have been assigned to stimulation of 2 to 8 amps of Luteal Lupron/FSH or Luteal Lupron FSH/HMG.
Exclusion
- Women who have had more than 3 previous IVF/ET cycles
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
468 Patients enrolled
Trial Details
Trial ID
NCT00656201
Start Date
July 1 2003
End Date
July 1 2009
Last Update
September 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115